Log In
Print
BCIQ
Print
Print this Print this
 

Oxycyte

  Manage Alerts
Collapse Summary General Information
Company Oxygen Biotherapeutics Inc.
DescriptionPerfluorocarbon-based IV therapeutic oxygen carrier
Molecular Target Not applicable
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationShock / trauma
Indication DetailsTreat hemorrhagic shock; Treat traumatic brain injury (TBI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today